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A case of late presentation of precocious puberty due to pituitary astrocytoma
Późne rozpoznanie przedwczesnego pokwitania związanego z obecnością gwiaździaka 
przysadki. Opis przypadku
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The importance of assessing precocious puberty, especially in boys, is not only due to the great complications it has for 
the affected patients, but also to the fatal underlying diseases. Therefore, children with central precocious puberty should 
first undergo neuroimaging. In this case study, we present a 9.5-year-old boy who was referred to Rasoul-e-Akram Medical 
Center with increased intracranial pressure, nausea/vomiting, and severe headache having begun three months earlier. 
The development of secondary sexual changes had started two years earlier, and had been neglected. His testes, penis, and 
pubic hair were at the fourth Tanner stage. He had elevated luteinizing and follicle stimulating hormones. Microscopic 
evaluation confirmed low-grade pilocytic astrocytoma WHO grade 1. Emergency brain surgery was conducted in which 
the brain was decompressed, and chemotherapy was started postoperatively. Two years after the surgery, he remains under 
chemotherapy, with obvious sexual maturation and a height of 154 cm. Training families and medical staff efficiently can 
help prevent the late diagnosis and treatment of precocious puberty and, as a result, help patients in their social life.
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Ocena przedwczesnego pokwitania, szczególnie występującego u chłopców, jest niezwykle istotna nie tylko ze względu 
na poważne powikłania, na które narażony jest pacjent, lecz także z uwagi na chorobę podstawową, która może mieć 
charakter śmiertelny. Z  tego powodu dzieci dotknięte przedwczesnym pokwitaniem typu centralnego powinny 
w pierwszej kolejności zostać poddane badaniom neuroobrazowym. W niniejszej pracy przedstawiamy przypadek 
9,5-letniego chłopca, który został skierowany do Centrum Medycznego Rasoul-e-Akram ze wzmożonym ciśnieniem 
śródczaszkowym, nudnościami i wymiotami oraz silnymi bólami głowy trwającymi od trzech miesięcy. Rozwój 
drugorzędowych cech płciowych rozpoczął się u pacjenta 2 lata wcześniej i został zbagatelizowany. Jądra, penis oraz 
owłosienie łonowe pacjenta znajdowały się w stadium rozwoju odpowiadającym czwartemu stopniowi skali Tannera. 
Stwierdzono podwyższony poziom LH oraz FSH. Badanie histopatologiczne potwierdziło obecność gwiaździaka 
włosowatokomórkowego o stopniu złośliwości G1. U pacjenta wykonano operację odbarczającą w trybie pilnym. 
Po zabiegu wdrożono chemioterapię. Po upływie 2 lat od operacji chłopiec nadal otrzymuje chemioterapię, osiągnął 
154 cm wzrostu i przejawia oczywiste cechy dojrzałości płciowej. Prowadzenie właściwej edukacji rodzin oraz personelu 
medycznego może zapobiec zbyt późnemu rozpoznawaniu i wdrażaniu leczenia przedwczesnego pokwitania, tym samym 
ułatwiając pacjentom prowadzenie normalnego życia, dostosowanego do ich wieku i potrzeb społecznych.
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INTRODUCTION
Precocious puberty (PP), more frequent in girls (Muir, 2006), is defined as evolving physical chang-es of secondary sexual characteristics before the age 
of 8 years in girls and 9 years in boys, although the exact 
age may vary based on ethnicity or other factors (Carel 
et al., 2009). In Iran, the mean age of puberty in girls has 
been reported to be 10.14, and precocious puberty is de-
fined as occurring before the age of 7.5 years (Moayeri 
and Oloomi, 2006), higher in rural areas and in lower-ed-
ucation families (Delavar and Hajian-Tilaki, 2008), and 
9.7 years in boys (Razzaghi Azar et al., 2006). Regarding 
the involvement of the hypothalamic-pituitary-gonad-
al axis, PP may be classified as central PP (CPP), arising 
from central nervous system (CNS) or peripheral PP (PPP) 
(Carel and Léger, 2008). CPP is mostly idiopathic in girls, 
but in more than half of boys an identifiable aetiology, 
commonly a space-occupying lesion (Ducharme and Col-
lu, 1982), can be detected (Klein, 1999). Some studies have 
also described secondary aetiologies, such as high doses 
of radiation following brain tumours, trauma, infection, 
or an underlying disease like neurofibromatosis (Gleeson 
and Shalet, 2004).
Therefore, brain study, alongside hormonal assessment, is 
essential in each CPP case, especially in boys. On the other 
hand, CPP may be related to various origins (Bierich, 1975), 
which highlights the need for precise evaluations.
Here, we present the case of a 9.5-year-old boy with CPP 
originating from midline low-grade astrocytoma involving 
hypothalamus, who was presented to us with nausea and 
vomiting of three months.
CASE REPORT
The patient was a 9.5-year-old boy from one of the north-
east rural areas of Iran, who was referred to Hazrat Rasoul-
e-Akram Hospital in November 2013. He was the eighth 
child of the family, born full-term with no complications, 
by vaginal delivery. His birth weight and height were within 
normal range. He had no underlying disease, family histo-
ry of brain tumours, or any endocrine disease. The devel-
opment of secondary sexual changes, which had begun two 
years earlier, was treated herbally.
On admission, he had nausea/vomiting and severe head-
aches which had started three months earlier, and was de-
veloping losses of consciousness. He had no history of 
blindness or sensational disorders, or any history of seizures 
or dyslexia. His height at the time was 145 cm (z-score of 
1.3 and 90.8% of percentile), and he weighed 40 kg (90% 
of percentile). He had a deep voice and was moody.
In physical examination, he revealed hyperpigmented skin 
and intact cranial nerves, but signs of increased intracra-
nial pressure were detected in fundoscopy of the optic disc. 
His testes, penis, and pubic hair were at the fourth Tanner 
stage, with more than 4cc testicular volume (Fig. 1). 
Paraclinical assessments showed bone age matching 
14 years of age, and high basal values of luteinizing hor-
mone (LH) and follicle stimulating hormone (FSH). All 
important serum tests are demonstrated in Tab. 1. Other 
serum parameters were within normal range. The magnet-
ic resonance imaging (MRI) of the brain revealed a huge 
suprasellar mass extending to the third ventricle, that was 
hypointense in T1WI and hyperintense in T2WI, with 
bright enhancement (45 × 33 × 35 mm) (Fig. 2 A).
Serum test Unit Patient’s value Normal range 
Luteinizing hormone (LH) mIU/ml 4.2 LH adult <7, pubertal age <0.4
Follicle stimulating hormone (FSH) mIU/ml 6.0 FSH adult 3–20, pubertal age <2
Testosterone ng/dl 460 Testosterone adult male: 270–1070, in 9–11 years <7–130 
Prolactin ng/ml 12 Prolactin <24 
Human chorionic gonadotropin (βHCG) mIU/ml <10 βHCG <5
Thyroid stimulating hormone µIU/ml 0.5 TSH 0.4–4
Tab. 1. Important hormonal serum tests of the patient
Fig. 1.  The maturation of the patient’s genitalia
A case of late presentation of precocious puberty due to pituitary astrocytoma
93
AKTUALN NEUROL 2015, 15 (2), p. 91–95 DOI: 10.15557/AN.2015.0013
Emergency brain surgery was conducted: after right side 
pterional craniotomy and trans-sylvian approach to the 
suprasellar region, a hypothalamic-chiasmal mass ap-
peared and was partially removed, and chemotherapy 
was started postoperatively. The chemotherapy includ-
ed 6 courses, at 6-week intervals, consisting of vincristine 
(VCR), lomustine (CCNU), and procarbazine.
The pathologic evaluation confirmed low-grade pilocyt-
ic astrocytoma WHO grade 1; macroscopic result showed 
suprasellar intraventricular tumour, consisting of multi-
ple pieces of brown soft tissue measuring 3 × 3 × 1 cm and 
6 gr in weight, S.O.S:M/3, E:100%, and microscopic evalu-
ation confirmed biphasic neoplastic tissue with hyper and 
hypocellular zones revealing cells with slightly pleomor-
phic and enlarged nuclei in fibrillary background. Scat-
tered eosinophilic granular body was seen. Also, foci of 
haemorrhage were noted (Fig. 3). Post-op MRI revealed 
suprasellar mass with less enhancement (13 × 20 × 15 mm) 
(Fig. 2 B).
Gonadotropin-releasing hormone (GnRH) agonist (Dife-
relin) 3.75 mg was administered to the patient every 
28 days; nevertheless, the patient showed no compliance 
for hormone therapy, and as a result of economic prob-
lems, did not continue hormonal medication. Two years 
after follow-up, the patient has matured genitalia, bone age 
matching 18 years, and a height of 154 cm.
DISCUSSION
In the present case report, the 9.5-year-old child was at 
Tanner stage 4, although Iranian studies have reported the 
mean age of the fourth Tanner stage to be 13.9 for boys 
(Razzaghi Azar et al., 2006). 
In this case, the patient was referred very late to a phy-
sician, with PP progress already neglected for two years, 
which resulted in his mature sexual and bone age. 
Therefore, hormonal therapy would not have helped him 
greatly anyway, yet he failed to complete it.
As PP affects the child’s final height, and causes social dif-
ficulties for the patient, providing a thorough investigation 
on the details of this matter is critical for the sake of time-
ly and proper diagnosis and treatment. Also, developing 
adequate knowledge concerning puberty is important for 
the entire healthcare system and society, so that primary 
prevention programmes related to sexual health education 
and adolescent mental health may be planned and execut-
ed (Ahmadi et al., 2009).
Accordingly, paying sufficient attention to the examina-
tion of the genitals and assessment of sexual growth is es-
sential for every child referred to a physician. The present-
ed patient may have benefited more from treatment, had 
he been referred earlier.
Fig. 2.  Magnetic resonance imaging (MRI) findings of the patient. Fig. A represents the pre-operation imaging (a huge suprasellar mass 
extending to the third ventricle, hypointense in T1WI and hyperintense in T2WI with bright enhancement (45 × 33 × 35 mm), and 
Fig. B demonstrates the postoperation imaging (suprasellar mass with less enhancement, of 13 × 20 × 15 mm)
Fig. 3.  Microscopic evaluation of the brain pathology: biphasic 
neoplastic tissue with hyper- and hypocellular zones re-
vealing cells with slightly pleomorphic and enlarged nu-
clei in fibrillary background, with scattered eosinophilic 
granular body and foci of haemorrhage
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As other studies have indicated, pubertal age is closely re-
lated to race, yet few studies have evaluated boys’ pubertal 
age in Iran. As Ahmadi et al. (2009) indicated, assessing pu-
berty in boys is limited, as Iranian boys feel embarrassed to 
express or discuss their genital changes. Some other Irani-
an conveys have also specified the stressful complications 
the Iranian adolescents face during puberty (Golchin et al., 
2012; Koohestani et al., 2009).
Early puberty, medically known as precocious puberty, has 
thus rarely been investigated in Iranian population. One 
case has been reported, of a 6.5-year-old boy referred for 
PP due to Leydig cell tumour of testis (Ghazi et al., 2001), 
which is a type of peripheral PP. Spermatogenesis in males 
or ovulation in females appear only in CPP, and therefore 
adult-sized testicles can be noticed in this type only, as in 
the present case (Jolly, 1951).
Many studies have reported cases of CPP due to brain tu-
mours. Hamartomas, teratomas, or ependymomas have 
been reported in many cases, and some state them to be the 
most common causes of CPP (Choi et al., 2013). Some have 
even proposed classic triads for the diagnosis of hamartoma 
(Nebesio and Eugster, 2007).
Other pathologies, such as optic glioma, astrocytoma, 
chorioepitheliomas, or neurofibromas have also been pro-
posed as possible aetiologies (Ducharme and Collu, 1982). 
However, the details have not been widely assessed. A sim-
ilar Iranian case report has reported PP in a 3-year-old boy 
with remarkable failure to thrive and nystagmus, which 
was ultimately found to be due to hypothalamic pilocytic 
astrocytoma (Vakili et al., 2004). He had high levels of LH 
and FSH, similar to the present case, but also high thyroid 
stimulating hormone (TSH). His case, however, was due to 
diencephalic syndrome, and all presentations were associ-
ated with radiation and tumour resection.
Some suggest that the involvement of posterior hypothala-
mus associated with an intact pituitary gland can be the sin-
gle reason to induce PP (Jolly, 1951).
Some other studies have investigated more cases with lon-
ger follow-ups. Choi et al. (2013) studied 61 boys, and re-
ported two cases of pilocytic astrocytoma. Jakubowska et al. 
(2011) followed 39 girls and 17 boys diagnosed with PP for 
10 years, reporting 6 boys to reveal gonadotropin-depen-
dent central puberty: 5 cases were idiopathic, and one had 
a brain tumour – astrocytoma. As it seems, the case present-
ed is a rare phenomenon.
Thus, more studies need to be conducted in order to explain 
the cause, the best diagnostic criteria, specific treatment, or 
any accompanying syndromes regarding this rare brain tu-
mor causing precocious puberty.
Primary CNS tumours in Iran have been reported to 
have an incidence of 2.74 per 100,000 person-years with 
a benign to malignant ratio of 1.07 (Jazayeri et al., 2013). 
Another Iranian study has indicated 84% of all brain 
tumours to be meningioma (26%), followed by astrocy-
toma (23.4%), pituitary adenoma (14.2%), glioblastoma 
(5.1%), and ependymoma (4.8%), and has reported male 
predominance in astrocytoma tumours, with a ratio of 
1.5 (Mehrazin et al., 2006). A recent study in Northeast 
of Iran investigated 87 non-brainstem astrocytoma cas-
es, and has reported the best treatment to be gross to-
tal resection with 100% survival rate for grade 1 (Anvari 
et al., 2014), as in the presented case. A neuro-endocri-
nology meeting in Mashhad has also indicated resection 
as the most effective treatment (Anvari et al., 2011). They 
have suggested temozolomide (TMZ) for treatment of 
most brain tumours, including astrocytoma. The patient 
in our case, however, responded to the chemotherapy reg-
imen explained above.
We report this case with the intention to highlight the 
importance of educating medical staff and families in the 
appropriate diagnosis and treatment of this endocrine 
dysfunction which has a noticeable effect on the quality 
of life of the affected patients.
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